Volume 5, Issue 5, October 2017, Page: 62-69
Marine Organisms as Biomedical Resources Enrich Quality of Life
Silpa Somavarapu, Department of Food Technology, Vikrama Simhapuri University, Nellore, India
Received: Sep. 10, 2017;       Accepted: Sep. 22, 2017;       Published: Nov. 27, 2017
DOI: 10.11648/j.cbb.20170505.12      View  1422      Downloads  49
Abstract
The Ocean, called the ‘mother of origin of life’, is a rich source of biological and chemical diversity. Marine floras include microflora (bacteria, actinobacteria, cyanobacteria and fungi), microalgae, macroalgae (seaweeds), and flowering plants (mangroves and other halophytes). Marine organisms have unique properties as they are exposed to extreme marine environmental conditions. This vast marine floral resource offer a great way for discovery of new drugs which can fight deadly diseases like cancer, acquired immune deficiency syndrome (AIDS), arthritis, etc. Sea has got plenty of metabolites and other resources in living or dead form. Thermo-stable proteases, lipases, esterases, and starch and xylan degrading enzymes have been actively sought from bacterial and archaeal hyperthermophilic marine microorganisms. Marine cyanobacteria appear to be potential sources for production of vitamins such as B complex group and vitamin-E. The carotenoids and phycobiliprotein pigments of cyanobacteria have commercial value as natural food colouring agents, as feed additives, as enhancers of the color of egg yolks, to improve the health and fertility of cattle, as drugs and in the cosmetic industries. Some anti-HIV activity has been observed with the compounds extracted from Lyngbya lagerhaimanii and Phormidium tenue. Thus an attempt to review few marine derived biomedical resources was done emphasizing that with the advent of modern technologies it is anticipated that the marine environment will become an invaluable source of novel compounds in the future.
Keywords
Marine Floras, Hyperthermophilic, Marine Cyanobacteria, Lyngbya lagerhaimanii
To cite this article
Silpa Somavarapu, Marine Organisms as Biomedical Resources Enrich Quality of Life, Computational Biology and Bioinformatics. Vol. 5, No. 5, 2017, pp. 62-69. doi: 10.11648/j.cbb.20170505.12
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Demain AL, Zhang L: Natural products and drug discovery. In Natural Products: Drug Discovery and Therapeutics Medicines. Edited by Zhang L, Demain A. Humana Press; 2005: 3-32.
[2]
Hill, R. T.; Fenical, W. Pharmaceuticals from marine natural products: Surge or ebb? Curr. Opin. Biotechnol. 2010, 21, 777–779.
[3]
Yap, C. Y.; Chen, F. Polyunsaturated fatty acids: Biological significance, biosynthesis, and production by microalgae and microalgae-like organisms. In Algae and Their Biotechnological Potential; Chen, F., Jiang, Y., Eds.; Kluwer Academic Publishers: Dordrecht, The Netherlands, 2001; pp. 1–32.
[4]
Thoms, C.; Schupp, P. J. Chemical defense strategies in sponges: A review. In Porifera Research: Biodiversity, Innovation and Sustainability; Custodio, M. R., Hajdu, G. L., Hajdu, E., Muricy, G., Eds.; IMOS: Rio de Janeiro, Museu Nacional, Brazil, 2007; pp. 627–637.
[5]
Gochfeld DJ, El Sayed KA, Yousaf M, Hu JF, Bartyzel P, Dunbar DC, Wilkins SP, Zjawiony JK, Schinazi RF, Schlueter Wirtz S et al.: Marine natural products as lead anti-HIV agents. Mini Rev Med Chem 2003, 3: 401-424.
[6]
Kim, S.; Pallela, R. Medicinal Foods from Marine Animals: Current Status and Prospects. Adv. Food Nutr. Res. 2012, 65, 1–9.
[7]
Vo, T. S.; Kim, S. K. Potential anti-HIV agents from marine resources: An overview. Mar. Drugs 2010, 8, 2871–2892.
[8]
Wijesekara, I.; Kim, S. K. Angiotensin-i-converting enzyme (ACE) inhibitors from marine resources: Prospects in the pharmaceutical industry. Mar. Drugs 2010, 8, 1080–1093.
[9]
Di-Bernardini, R.; Harnedy, P.; Bolton, D.; Kerry, J.; O’Neill, E.; Mullen, A. M.; Hayes, M. Antioxidant and antimicrobial peptidic hydrolysates from muscle protein sources and by-products. Food Chem. 2011, 124, 1296–1307.
[10]
Agyei, D.; Danquah, K. Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnol. Adv. 2011, 29, 272–277.
[11]
Harris, K. A.; Hill, A. M.; Kris-Etherton, P. M. Health benefits of marine derived omega-3 fatty acids. ACSMS Health Fit. J. 2010, 14, 22–28.
[12]
Honypattarakere, T.; Cherntong, N.; Wickienchot, S.; Kolida, S.; Rastall, R. A. In vitro prebiotic evaluation of exopolysaccharides produced by marine isolated lactic acid bacteria. Carbohydr. Polym. 2012, 87, 846–852.
[13]
Newman DJ, Cragg GM: The discovery of anticancer drugs from natural sources. In Natural Products: Drug Discovery and Therapeutics Medicines. Edited by Zhang L, Demain A. Humana Press; 2005: 275-294.
[14]
Streit WR, Schmitz RA: Metagenomics—the key to the uncultured microbes. Curr Opin Microbiol 2004, 7: 492-498. This paper is a remarkable overview of the recent progress in metagenome technology.
[15]
Kim EY, Kim DG, Kim YR, Hwang J, Nam TJ, Kong IS: An improved method of protein isolation and proteome analysis with Saccharina japonica (Laminariales) incubated under different pH conditions. J. Appl. Phycol. 2011, 23, 123–130.
[16]
Jiao G, Yu G, Zhang J, Ewart HS: Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar. Drugs 2011, 9, 196–233.
[17]
Kim S, Pallela R. Medicinal Foods from Marine Animals: Current Status and Prospects. Adv. Food Nutr. Res. 2012, 65, 1–9.
[18]
Herpandi NH, Rosma A, Wan NWA. The Tuna Fishing Industry: A New Outlook on Fish Protein Hydrolysates. Compr. Rev. Food Sci. Food Saf. 2011, 10, 195–207.
[19]
Vo TS, Kim SK. Potential anti-HIV agents from marine resources: An overview. Mar. Drugs 2010, 8, 2871–2892.
[20]
Wijesekara I, Kim SK. Angiotensin-i-converting enzyme (ACE) inhibitors from marine resources: Prospects in the pharmaceutical industry. Mar. Drugs 2010, 8, 1080–1093.
[21]
Hu GP, Yuan J, Sun L, She ZG, Wu JH, Lan XJ, Zhu X, Lin YC, Chen SP. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar. Drugs 2011, 9, 514–525.
Browse journals by subject